The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality: A Multicenter Study
Abstract
CONTEXT: Tumor necrosis factor alpha (TNF-alpha) is believed to be a cytokine central to pathogenesis of septic shock. TNF2, a polymorphism within the TNF-alpha gene promoter, has been associated with enhanced TNF-alpha production and negative outcome in some severe infections. OBJECTIVES: To investigate the frequency of the TNF2 allele in patients with septic shock and to determine whether the allele is associated with the occurrence and outcome of septic shock. DESIGN: Multicenter case-control study conducted from March 1996 to June 1997. SETTING: Seven medical intensive care units in university hospitals. SUBJECTS: Eighty-nine patients with septic shock and 87 healthy unrelated blood donors. MAIN OUTCOME MEASURES: Frequency of the TNF2 allele among patients with septic shock and among those who died and the level of corresponding TNF-alpha concentrations. RESULTS: Mortality among patients with septic shock was 54%, consistent with the predicted mortality from the Simplified Acute Physiologic Score (SAPS II) value. The polymorphism frequencies of the controls and the patients with septic shock differed only at the TNF2 allele (39% vs 18% in the septic shock and control groups, respectively, P =.002). Among the septic shock patients, TNF2 polymorphism frequency was significantly greater among those who had died (52% vs 24% in the survival group, P =.008). Concentrations of TNF-alpha were higher in 68% and 52% with the TNF2 and TNF1 polymorphisms, respectively, but their median values (48 pg/mL vs 29 pg/mL) were not statistically different (P = .31). After controlling for age and the probability of death, derived by the SAPS II score, multiple logistic regression analysis showed that, for the same rank of SAPS II value, patients with the TNF2 allele had a 3.7-fold risk of death (95% confidence interval, 1.37-10.24). CONCLUSION: The TNF2 allele is strongly associated with susceptibility to septic shock and death due to septic shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
Genetic Dissection of Complex Traits
Lander, E. S., & Schork, N. J. (1994) · Science · doi:10.1126/science.8091226 · Cited by 3,413
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,218
Detection of circulating tumor necrosis factor after endotoxin administration
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
McGuire, W., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,169
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
The −308 tumor necrosis factor-α promoter polymorphism effects transcription
Kroeger, K. M., Carville, K. S., & Abraham, L. J. (1997) · Molecular Immunology · doi:10.1016/s0161-5890(97)00052-7 · Cited by 864
Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious Purpura
Girardin, E., Grau, G. E., Dayer, J.-M., Roux-Lombard, P., the J5 Study Group*, & Lambert, P.-H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190703 · Cited by 737
Wilson, A. G., de Vries, N., Pociot, F., di Giovine, F. S., van der Putte, L. B., & Duff, G. W. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.557 · Cited by 675
Jacob, C. O., Fronek, Z., Lewis, G. D., Koo, M., Hansen, J. A., & McDevitt, H. O. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1233 · Cited by 627
Louis, E., Franchimont, D., Piron, A., Gevaert, Y., Schaaf-Lafontaine, N., Roland, S., Mahieu, P., Malaise, M., De Groote, D., Louis, R., et al. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00662.x · Cited by 575
Tumor necrosis factors: developments during the last decade.
Aggarwal, B. B., & Natarajan, K. (1996) · PubMed · Cited by 566
Calandra, T., Baumgartner, J.-D., Grau, G. E., Wu, M.-M., Lambert, P.-H., Schellekens, J., Verhoef, J., Glauser, M. P., & Swiss-Dutch J5 Immunoglobulin Study Group (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.5.982 · Cited by 547
Proinflammatory and Anti-inflammatory Cytokines as Mediators in the Pathogenesis of Septic Shock
Dinarello, C. A. (1997) · Chest · doi:10.1378/chest.112.6_supplement.321s · Cited by 508
Cohen, J., & Carlet, J. (1996) · Critical Care Medicine · doi:10.1097/00003246-199609000-00002 · Cited by 501
BOUMA, G., CRUSIUS, J. B. A., OUDKERK POOL, M., KOLKMAN, J. J., VON BLOMBERG, B. M. E., KOSTENSE, P. J., GIPHART, M. J., SCHREUDER, G. M. T., MEUWISSEN, S. G. M., & PEÑA, A. S. (1996) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1996.d01-65.x · Cited by 373
Nadel, S., Newport, M. J., Booy, R., & Levin, M. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.4.878 · Cited by 305
Polymorphisms in the Coagulation Factor VII Gene and the Risk of Myocardial Infarction
Iacoviello, L., Di Castelnuovo, A., de Knijff, P., D'Orazio, A., Amore, C., Arboretti, R., Kluft, C., & Donati, M. B. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380202 · Cited by 278
Genetic Polymorphisms in the Tumor Necrosis Factor Locus Influence Non-Hodgkin's Lymphoma Outcome
Warzocha, K., Ribeiro, P., Bienvenu, J., Roy, P., Charlot, C., Rigal, D., Coiffier, B., & Salles, G. (1998) · Blood · doi:10.1182/blood.v91.10.3574 · Cited by 272
MØLVIG, J., BAEK, L., CHRISTENSEN, P., MANOGUE, K. R., VLASSARA, H., PLATZ, P., NIELSEN, L. S., SVEJGAARD, A., & NERUP, J. (1988) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1988.tb02404.x · Cited by 259
Wakabayashi, G., Gelfand, J. A., Jung, W. K., Connolly, R. J., Burke, J. F., & Dinarello, C. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115218 · Cited by 248
Association of an HLA-DQ Allele With Clinical Tuberculosis
Goldfeld, A. E. (1998) · JAMA · doi:10.1001/jama.279.3.226 · Cited by 244
Stüber, F., Udalova, I. A., Book, M., Drutskaya, L. N., Kuprash, D. V., Turetskaya, R. L., Schade, F. U., & Недоспасов, С. А. (1995) · PubMed · Cited by 242
Bone, R. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540070061032 · Cited by 224
Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases.
Wilson, A. G., di Giovine, F. S., & Duff, G. W. (1995) · PubMed · Cited by 151
Rogaeva, E. A., Premkumar, S., Song, Y., Sorbi, S., Brindle, N., Paterson, A., Duara, R., Levesque, G., Yu, G., Nishimura, M., et al. (1998) · JAMA · doi:10.1001/jama.280.7.614 · Cited by 150
CDP571, a humanized antibody to human tumor necrosis factor-alpha
Dhainaut, J.-F., Vincent, J., Richard, C., Lejeune, P., Martin, C., Fierobe, L., Stephens, S., Ney, U. M., & Sopwith, M. (1995) · Critical Care Medicine · doi:10.1097/00003246-199509000-00004 · Cited by 148
Self-citationFunctional Analysis of a New Polymorphism in the Human TNF α Gene Promoter
Pociot, F., D’Alfonso, S., Compasso, S., Scorza, R., & Richiardi, P. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03686.x · Cited by 148
Recent Progress in the Tumor Necrosis Factor-α Field
Rink, L., & Kirchner, H. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237369 · Cited by 142
Genetic Variability in the TNF-α Promoter Is Not Associated with Type II Diabetes Mellitus (NIDDM)
Hamann, A., Mantzoros, C. S., Vidal‐Puig, A., et al. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1887 · Cited by 140
Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases
Hurme, M., Lahdenpohja, N., & Santtila, S. (1998) · Annals of Medicine · doi:10.3109/07853899809002488 · Cited by 134
Current Understanding of Sepsis
Wenzel, R. P., Pinsky, M. R., Ulevitch, R. J., & Young, L. D. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.3.407 · Cited by 129
Polymorphism at the TNF loci in rheumatoid arthritis
Vinasco, J., Beraún, Y., Nieto, A., Fraile, A., Matarán, L., Pareja, E., & Martin, J. J. (1997) · Tissue Antigens · doi:10.1111/j.1399-0039.1997.tb02715.x · Cited by 128
Adjunctive Therapy for Septic Shock: A Review of Experimental Approaches
Lynn, W. A., & Cohen, J. B. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.143 · Cited by 121
Keel, M. J. B., Ecknauer, E., Stocker, R. A., Ungethüm, U., Steckholzer, U., Kenney, J. S., Gallati, H., Trentz, O., & Ertel, W. (1996) · doi:10.1097/00005373-199606000-00008 · Cited by 89
Andrejko, K. M., & Deutschman, C. S. (1996) · Critical Care Medicine · doi:10.1097/00003246-199612000-00004 · Cited by 38
Cited by
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Opal, S. M., & DePalo, V. A. (2000) · Chest · doi:10.1378/chest.117.4.1162 · Cited by 1,752
Cytokine storm and sepsis disease pathogenesis
Chousterman, B. G., Swirski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,330
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Aird, W. C. (2003) · Blood · doi:10.1182/blood-2002-06-1887 · Cited by 1,131
Epidemiology of sepsis: an update
Angus, D. C., & Wax, R. S. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00035 · Cited by 813
“(36) TNF1/2 Incidence and severity (mortality) Case-control Caucasian, healthy blood donors Septic shock 89 cases, 87 controls”
Background
Metadata
- Authors
- Mira, J.-P., Cariou, A., Grall, F., Delclaux, C., Losser, M.-R., Heshmati, F., Cheval, C., Monchi, M., Teboul, J.-L., Riché, F., Leleu, G., Arbibe, L., Mignon, A., Delpech, M., & Dhainaut, J.-F.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1999-08-11
- Volume
- 282
- Issue
- 6
- Pages
- 561
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2141380939
- Cited by
- 740
- References
- 39
- FWCI
- 41.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.